Ductal carcinoma in situ: Value of sentinel lymph node biopsy

Journal of Surgical Oncology

Volumn 94, Issue 5, 2006, Pages 426-430

  Sakr, Rita ^a   Barranger, Emmanuel ^a   Antoine, Martine ^a   Prugnolle, Herve ^a   Daraï, Emile ^a   Uzan, Serge ^a  

^a HÔPITAL TENON   (France)

Author keywords

Breast; Immunohistochemistry; Large ductal carcinoma in situ; Microinvasion; Sentinel lymph node; Upstaging

Indexed keywords

DISULFINE BLUE; EOSIN; HEMATOXYLIN; NANOCIS; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER SIZE; CANCER STAGING; CARCINOMA IN SITU; DIAGNOSTIC VALUE; DUCTAL CARCINOMA IN SITU; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MICROMETASTASIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; REVIEW; SCINTILLATION CAMERA; SCINTIMAMMOGRAPHY; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MASTECTOMY, SEGMENTAL; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 33749071374     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20578     Document Type: Review

References (30)

1. Adamovich T, Simmons R: Ductal carcinoma in situ with microinvasion. Am J Surg 2003;186:112-116.
2. Schwartz GF, Solin LJ, Olivotto IA, et al.: Consensus conference on the treatment of in situ ductal carcinoma of the breast. 1999. Cancer 2000;88:946-954.
3. Mokbel K: Towards optimal management of ductal carcinoma in situ of the breast. Eur J Surg Oncol 2003;29:191-197.
4. Anderson B: Axillary metastases with DCIS: Is the glass half empty or half full? Ann Surg Oncol 2000;7:631-633.
5. Silverstein M, Skinner K, Lomis T: Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 2001;25:767-772.
6. Kelly T, Kim J, Patrick R, et al.: Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ. Am J Surg 2003;186:368-370.
7. Lyman GH, Giuliano AE, Somerfield MR, et al: American society of clinical oncology guideline for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-7720.
8. Silverstein MJ, Lagios MD, Recht A, et al.: Image-detected breast cancer: State of the art diagnosis and treatment. J Am Coll Surg 2005;201:586-597.
9. Cox C, Nguyen K, Gray R, et al.: Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): Why map DCIS? Am Surg 2001;67:513-521.
10. Intra M, Veronesi P, Mazzarol G, et al.: Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003;138:309-313.
11. Le Bouëdec G, Penault-Llorca F, de Latour M, et al.: Microinvasive ductal carcinoma of the breast. Role of axillary lymph node dissection. J Gynecol Obstet Biol Reprod 1999;28:10-16 [in French].
12. Zavotsky J, Hansen N, Brennan M, et al.: Lymph node metastasis from ductal carcinoma in situ with microinvasion. Cancer 1999;85:2439-2443.
13. Sakorafas G, Farley D: Optimal management of ductal carcinoma in situ of the breast. Surg Oncol 2003;12:221-240.
14. Cserni G: Sentinel lymph node biopsy as a tool for the staging of ductal carcinoma in situ in patients with breast carcinoma. Surg Today 2002;32:99-103.
15. Weaver D: Occult "micrometastases" in ductal carcinoma in situ. Cancer 2003;98:2083-2087.
16. Bedrosian I, Reynolds C, Mick R, et al.: Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 2000;88:2540-2545.
17. Pendas S, Dauway E, Giuliano R, et al.: Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000;7:15-20.
18. Klauber-Demore N, Tan L, Lieberman L, et al.: Sentinel lymph node biopsy: Is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000;7:636-642.
19. Sakorafas G, Tsiotou A: Ductal carcinoma in situ of the breast: Evolving perspectives. Cancer Treat Rev 2000;26:103-125.
20. Tamhane R, Dahlstrom J, McCallum D, et al.: The clinical significance of cytokeratine-positive cells in lymph nodes at the time of mastectomy from patients with ductal carcinoma in situ. Ann Surg Oncol 2002;9:999-1003.
21. McMasters K, Chao C, Wong S, et al.: Sentinel lymph node biopsy in patients with ductal carcinoma in situ - a proposal. Cancer 2002;95:15-20.
22. Pendas S, Jakub J, Giuliano R, et al.: The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapy. Cancer Control 2004;11:231-235.
23. Baxter NN, Virnig BA, Durham SB, et al.: Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004;96:443-448.
24. Fuhrman GM: Sentinel lymph node mapping and biopsy for ductal carcinoma in situ and other controversial indications. Am Surg 2004;70:403-406.
25. Lara J, Young S, Vellila R, et al.: The relevance of occult axillary micrometastases in ductal carcinoma in situ. Cancer 2003;98:2105-2113.
26. Tabar L, Chen HH, Duffy SW, et al.: A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancer: A prospective study. Lancet 2000;355:429-433.
27. De Mascarel I, MacGrocan G, Picot V, et al.: Prognostic significance of immunohistochemically detected breast cancer node metastases in 218 patients. Br J Cancer 2002;87:70-74.
28. De Mascarel I, Soubeyran I, MacGrocan G, et al.: Immunohistochemically detected lymph node metastases from breast carcinoma: Practical considerations about the new American Joint Committee on Cancer classification. Cancer 2005;103:1319-1322.
29. Zelis J, Sickle-Santanello B, Liang W, et al.: Do not contemplate invasive surgery for ductal carcinoma in situ. Am J Surg 2002;184:348-349.
30. Wilkie C, White L, Dupont E, et al.: An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 2005;190:563-566.